Citi Analysts Keep a Neutral View on 23andMe, Sets Target Price at $0.63

Monday, 3 June 2024, 16:42
In a recent report, Citigroup analysts continue to hold a neutral outlook on 23andMe, establishing a target price of $0.63. The analysis highlights the challenges faced by the company and the potential factors affecting its future performance. Despite the valuation, investors are advised to monitor developments closely to make informed decisions.
https://store.livarava.com/9eedbd49-21e2-11ef-a3fb-9d5fa15a64d8.jpg
Citi Analysts Keep a Neutral View on 23andMe, Sets Target Price at $0.63

Citi Maintains Neutral Stance on 23andMe with $0.63 Target

Citigroup analysts have reaffirmed their neutral stance on 23andMe with a target price of $0.63. The company faces challenges in the market, impacting its performance. Investors are cautioned to monitor developments for informed decisions.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe